U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.1210-34TG[12] AND not specified

Germline classification:
Benign (1 submission)
Last evaluated:
May 25, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000156213.14

Allele description [Variation Report for NM_000492.4(CFTR):c.1210-34TG[12]]

NM_000492.4(CFTR):c.1210-34TG[12]

Genes:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
CFTR-AS1:CFTR antisense RNA 1 [Gene - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.1210-34TG[12]
HGVS:
  • NC_000007.14:g.117548608GT[12]
  • NC_000007.14:g.117548608_117548609insTG
  • NG_016465.4:g.87825GT[12]
  • NM_000492.4:c.1210-34TG[12]MANE SELECT
  • LRG_663t1:c.1210-34_1210-33TG[12]
  • LRG_663:g.87825GT[12]
  • NC_000007.13:g.117188660_117188661insTG
  • NC_000007.13:g.117188662GT[12]
  • NC_000007.13:g.117188682_117188683dup
  • NC_000007.13:g.117188682_117188683dupGT
  • NM_000492.3:c.1210-33_1210-32insTG
  • NM_000492.3:c.1210-34_1210-33TG[12]
  • NM_000492.4:c.1210-13_1210-12dupMANE SELECT
Links:
dbSNP: rs3832534
NCBI 1000 Genomes Browser:
rs3832534
Molecular consequence:
  • NM_000492.4:c.1210-34TG[12] - intron variant - [Sequence Ontology: SO:0001627]
Observations:
21

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000197435Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Benign
(May 25, 2018)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided2021not providednot providednot providedclinical testing

Citations

PubMed

Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign.

Groman JD, Hefferon TW, Casals T, Bassas L, Estivill X, Des Georges M, Guittard C, Koudova M, Fallin MD, Nemeth K, Fekete G, Kadasi L, Friedman K, Schwarz M, Bombieri C, Pignatti PF, Kanavakis E, Tzetis M, Schwartz M, Novelli G, D'Apice MR, Sobczynska-Tomaszewska A, et al.

Am J Hum Genet. 2004 Jan;74(1):176-9. Epub 2003 Dec 18.

PubMed [citation]
PMID:
14685937
PMCID:
PMC1181905

Molecular study of (TG)m(T)n polymorphisms in Iranian males with congenital bilateral absence of the vas deferens.

Radpour R, Gourabi H, Gilani MA, Dizaj AV.

J Androl. 2007 Jul-Aug;28(4):541-7. Epub 2007 Feb 21.

PubMed [citation]
PMID:
17314234
See all PubMed Citations (8)

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000197435.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided20not providednot providedclinical testing PubMed (8)

Description

The c.1210-34TG[12]T[7] allele in intron 9 of the CFTR gene is classified as be nign because it has been identified in 43% (6544/15040) of East Asian chromosome s in the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs3832534). 930 homozygotes have also been identfied in the gnomAD databas e. ACMG/AMP Criteria applied: BA1

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided20not provided21not provided

Last Updated: Oct 26, 2024